WQ
ABBV icon

Wealth Quarterback’s AbbVie ABBV Stock Holding History

Wealth Quarterback’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$269K Sell
1,238
-25
-2% -$5.55K 0.11% 136
2025
Q4 		$289K Sell
1,263
-66
-5% -$15K 0.1% 128
2025
Q3 		$308K Buy
1,329
+7
+0.5% +$1.43K 0.12% 125
2025
Q2 		$245K Buy
1,322
+29
+2% +$5.39K 0.12% 123
2025
Q1 		$271K Sell
1,293
-229
-15% -$44.5K 0.15% 105
2024
Q4 		$270K Sell
1,522
-119
-7% -$21.9K 0.13% 98
2024
Q3 		$324K Sell
1,641
-401
-20% -$74.8K 0.17% 90
2024
Q2 		$350K Sell
2,042
-4,339
-68% -$719K 0.2% 81
2024
Q1 		$1.16M Sell
6,381
-1,899
-23% -$327K 0.65% 29
2023
Q4 		$1.28M Buy
8,280
+174
+2% +$25.4K 0.78% 21
2023
Q3 		$1.21M Sell
8,106
-502
-6% -$73.7K 1.05% 20
2023
Q2 		$1.16M Buy
8,608
+1,558
+22% +$228K 0.8% 22
2023
Q1 		$1.12M Sell
7,050
-170
-2% -$26K 0.95% 18
2022
Q4 		$1.17M Buy
7,220
+21
+0.3% +$3.22K 0.97% 20
2022
Q3 		$966K Buy
7,199
+2,851
+66% +$409K 1.03% 23
2022
Q2 		$666K Buy
+4,348
New +$664K 0.52% 42
2021
Q3 		$196K Sell
1,809
-327
-15% -$37.4K 0.13% 111
2021
Q2 		$241K Buy
+2,136
New +$241K 0.15% 102
2020
Q4 		$234K Sell
2,182
-504
-19% -$48.4K 0.19% 96
2020
Q3 		$264K Hold
2,686
– – 0.24% 91
2020
Q2 		$264K Buy
2,686
+245
+10% +$21.6K 0.24% 91
2020
Q1 		$186K Sell
2,441
-9,330
-79% -$795K 0.17% 110
2019
Q4 		$218K Buy
+11,771
New +$977K 0.19% 102

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wealth Quarterback's ABBV Position: Q1 2026 in Review

Wealth Quarterback reduced its AbbVie (ABBV) stake by 2% in Q1 2026, selling an estimated $5.55K and leaving 1,238 shares worth $269K. The position accounts for 0.11% of the portfolio, ranked #136.

Wealth Quarterback first reported a position in ABBV in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.28M in Q4 2023. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wealth Quarterback held 1,238 shares of AbbVie worth $269K as of Q1 2026.
  • Wealth Quarterback sold 25 AbbVie shares in Q1 2026, an estimated $5.55K.
  • AbbVie made up 0.11% of Wealth Quarterback's portfolio in Q1 2026, its #136 holding.
  • Wealth Quarterback first reported a position in AbbVie in Q4 2019 and has held it in 23 quarters since.
  • Wealth Quarterback's AbbVie position peaked at $1.28M in Q4 2023.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wealth Quarterback's 13F filing for Q1 2026, filed 9 Apr 2026.